Search

Your search keyword '"Yuzefpolskaya M"' showing total 1,235 results

Search Constraints

Start Over You searched for: Author "Yuzefpolskaya M" Remove constraint Author: "Yuzefpolskaya M"
1,235 results on '"Yuzefpolskaya M"'

Search Results

1. Baseline Quality-of-Life of Caregivers of Patients With Heart Failure Prior to Advanced Therapies: Findings From the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) Study

2. Correlation Between the Subtype of Anti-HLA Donor Specific Antibodies and Rejection Assessed by Molecular Microscope

3. Outcomes Comparison of Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock with Acute Decompensated Heart Failure versus Acute Myocardial Infarction

4. History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx)

6. Heart Transplantation in a Patient with Active Thyroid Cancer

7. Sublingual Microcirculation in Acute Mechanical Circulatory Support in Cardiogenic Shock

10. Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed

11. Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope

12. Sex Differences in Allograft Rejection After Heart Transplantation (HT). Molecular Microscope (MMDx) Results

13. Microcirculatory Dysfunction in Cardiogenic Shock

14. Should Living Alone be an Absolute Contraindication to HeartMate 3 Implantation: A Single Center Experience

16. Association of Sex Mismatch with Allograft Rejection After Heart Transplantation (HT) - Molecular Microscope (MMDx) Results

17. Clinical Utility of Molecular Microscope Diagnostic System (MMDx) in Heart Transplant Recipients: Moving Towards a New Paradigm

18. Impact of MTOR Inhibitors on Heart Allograft Rejection Using Tissue-Based Gene-Expression Profiling. Molecular Microscope (MMDx) Results

19. Does Multiorgan Transplantation Correlate with Reduced Rates of Rejection as Evaluated by the Molecular Microscope (MMDx)?

20. Impact and Outcomes of Induction Therapy on Donor-Derived Cell-Free DNA Levels and Peripheral Gene-Expression Profiling in Heart Transplant Recipients

21. LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope

22. Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus

25. Sodium Glucose Co-Transporter 2 Inhibitor Use in HeartMate 3 Patients

26. Effects of Belatacept Therapy on Gene Expression Profiling and Rejection in Heart Transplant Recipients: A Molecular Microscope (MMDx) Evaluation

27. Correlation Between Peripheral Gene-Expression Profiling (GEP-Allomap) and Tissue Gene-Expression in T-Cell Mediated Rejection Detection

28. Social Work Evaluation Domains Related to Caregiver Support and Mental Health are Strong Predictors of Risk of Readmission or Driveline Infection After HeartMate 3 (HM3)

29. CAV Grading by PET Provides Improved Risk Stratification Compared to CA

30. Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients

32. Myocardial Blood Flow Assessment with PET Improves Risk Stratification Among HT Recipients with CAV1

33. Short to Mid-Term Outcomes in Patients Bridged to Recovery Using Impella 5.5

34. Clinical Implications of Borderline Rejection Assessed by Molecular Microscope

35. Comparison of Microcirculatory Function in Patients with HeartMate 3 LVAD and Healthy Controls

39. Impact of MIC-A Antibodies on Antibody Mediated Rejection (ABMR). Molecular Microscope Results (MMDx)

41. Cystatin C-Based Estimated Glomerular Filtration Rate is Independently Associated with Long-Term Mortality in HeartMate3 Patients

42. Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients

43. Impact of Cytomegalovirus (CMV) Mismatch on Rejection Assessed by Molecular Microscope (MMDx)

45. Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients

47. Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls

48. Statins Reduce Inflammation, Oxidative Stress and Endothelial Cell Activation in a Model of Venous Congestion in Systolic Heart Failure Patients

49. Prediction of Patient Self-Management for Heartmate 3 LVAD

50. Microcirculatory Dysfunction Across SCAI Stages of Cardiogenic Shock

Catalog

Books, media, physical & digital resources